Your trusted source for investing success

Tag: AveXis

5 February IPOs on the NASDAQ

5 February IPOs on the NASDAQ

This month, investors can expect some new blood to enter the life science market, with five companies — Editas Medicine, BeiGene, Protestasis Therapeutics, AveXis, Cancer Prevention Pharmaceuticals— listing on the NASDAQ.

Enter Your Log In Credentials
×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network